Completed PHASE4 INTERVENTIONAL 2-arm NCT01510457

Milnacipran for Chronic Pain in Knee Osteoarthritis (KOA)

Milnacipran for the Pain, Sensory Sensitization and Mood Changes in Knee Osteoarthritis

Sponsor: Dr. Norman Harden

Conditions Chronic Pain Degenerative Joint Disease Knee Osteoarthritis

Updated 9 times since 2017 Last updated: May 26, 2015 Started: Nov 30, 2010 Primary completion: Oct 31, 2013 Completion: Oct 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01510457, this PHASE4 trial focuses on Chronic Pain and Degenerative Joint Disease and remains completed. Sponsored by Dr. Norman Harden, it has been updated 9 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Jan 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 4 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Aug 2017 — Jun 2018 [monthly]

Completed PHASE4
Feb 2017 — Aug 2017 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Nov 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dr. Norman Harden
Forest Laboratories

Data source: Shirley Ryan AbilityLab

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.